๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for TNBC

Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer NCT07844473NA1 site๐Ÿ“ Madinah King Faisal Specialist Hospital & Research Center ยท Tests: Super paramagnetic iron oxide bracketing injection CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites๐Ÿ“ Tucson๐Ÿ“ Aurora๐Ÿ“ Washington D.C. Personalis Inc. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs NCT06908928Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Aurora Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: bulumtatug fuvedotin, bulumtatug fuvedotin Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer NCT05541367n/a1 site๐Ÿ“ Wuhan Tongji Hospital PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC NCT06533384Phase 31 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Caโ€ฆ The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ๏ผšSingle-arm, Prospective, Open Clinical Study NCT06125080Phase 21 site๐Ÿ“ Wuhan Huihua Xiong ยท Tests: Utidelone, Tirelizumab, Bevacizumab Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) NCT04434040Phase 27 sites๐Ÿ“ San Francisco๐Ÿ“ Chicago๐Ÿ“ New Lenox Dana-Farber Cancer Institute ยท Tests: Atezolizumab, Sacituzumab govitecan SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) NCT06401005Phase 21 site๐Ÿ“ Wuhan Hubei Cancer Hospital ยท Tests: Cadonilimab (AK104) Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251Phase 1, Phase 213 sites๐Ÿ“ New Haven๐Ÿ“ Sarasota๐Ÿ“ Tampa Avenzo Therapeutics, Inc. ยท Tests: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer NCT07570524n/a1 site๐Ÿ“ Rennes Center Eugene Marquis ยท Tests: Additionnal breast biospy and blood sample First in Human Study of TUB-030 in Patients With Advanced Solid Tumors NCT06657222Phase 1, Phase 220 sites๐Ÿ“ New Haven๐Ÿ“ Miami๐Ÿ“ Boston Gilead Sciences ยท Tests: TUB-030 A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites๐Ÿ“ Syracuse๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxcel, Pembrolizumab Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214EARLY Phase 11 site๐Ÿ“ Stony Brook Alison Stopeck ยท Tests: CEDM, CEDBT, Omnipaque 350mgI/mL Solution for Injection A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02) NCT06682195Phase 213 sites๐Ÿ“ Nanchang๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: Neoadjuvant chemotherapy combined with Toripalimab Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) NCT05660083Phase 23 sites๐Ÿ“ Bethesda๐Ÿ“ Houston๐Ÿ“ Houston The Methodist Hospital Research Institute ยท Tests: L-NMMA SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC NCT06627712Phase 31 site๐Ÿ“ Sichuan West China Hospital ยท Tests: SBRT+PD-1 Inhibitor + Chemotherapy, PD-1 Inhibitor + Chemotherapy 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites๐Ÿ“ Kingswood๐Ÿ“ Wollongong๐Ÿ“ Southport Radiopharm Theranostics, Ltd ยท Tests: 177Lu-RAD204 Trop-2 Targeted PET Probes in Advanced TNBC NCT07046455NA1 site๐Ÿ“ Beijing Peking University Cancer Hospital & Institute ยท Tests: Sacituzumab Govitecan (SG) Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) NCT05909332Phase 315 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Fudan University ยท Tests: Antivascular therapy, Chemotherapy Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy NCT06880029Phase 1, Phase 21 site๐Ÿ“ Vila Nova de Gaia Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. ยท Tests: Morning pembrolizumab infusions ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC NCT07332975n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer NCT03150576Phase 2, Phase 330 sites๐Ÿ“ Cambridge๐Ÿ“ Burton-on-Trent๐Ÿ“ Manchester Cambridge University Hospitals NHS Foundation Trust ยท Tests: Olaparib, Paclitaxel and Carboplatin Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT) NCT07283692Phase 21 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Serplulimab, Paclitaxel, Carboplatin A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) NCT05999149Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai Fudan University ยท Tests: Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer NCT05862064Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: epirubicin,cyclophosphamide,paclitaxel,Carrelizumab, epirubicin,cyclophosphamide,paclitaxel Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion โ€ฆ ยท Tests: GTAEXS617, SoC Role of the Immune Environment in Response to Therapy in Breast Cancer NCT05396612n/a1 site๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine ยท Tests: Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA โ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy